QHSLab (USAQ)

USA Equities Corp. is a development stage company, which currently no operations and has determined to direct its efforts and limited resources to pursue acquisitions and/or effect a business combination, principally in incoming acquiring real estate. The company was founded on September 1, 1983 and is headquartered in West Palm Beach, FL.

Company profile

Ticker

USAQ

Exchange

OTC

Website

www.mabxa.com/

CEO

Troy Grogan

Incorporated

Nevada

Location

Florida

Fiscal year end

Dec 31

Sector

Technology Services > Biotechnology

Industry (SIC)

Surgical & Medical Instruments & Apparatus

3M • Baxter International • Boston Scientific • Stryker • Becton, Dickinson And • Teleflex • Resmed • Hill-Rom • Nuvasive • Integra Lifesciences ...

Former names

AMERICAN BIOGENETIC SCIENCES INC, USA EQUITIES CORP.

SEC CIK

0000856984

Corporate docs

Articles of Incorporation & Bylaws

Plans of Reorganization

Indentures

Material Contracts & Credit Agreements

Subsidiaries Lists

IRS number

112655906

USAQ stock data

1M 1Y 5Y

Press releases

From Benzinga Pro

QHSLab Announces New Strategic Alliance with Medical License Factory For its AllergiEnd® Products and Services

24 Jun 22

This Partnership Expands QHSLab's Independent Practitioner Network, While Addressing Current Industry Pain Points. WEST PALM BEACH, FL, June 24, 2022 (GLOBE NEWSWIRE) -- QHSLab, Inc. (OTCQB:USAQ), a company focused

QHSLab, Inc's CEO Addresses Current Market Conditions & Recent Quarterly Performance

24 May 22

WEST PALM BEACH, FL, May 24, 2022 (GLOBE NEWSWIRE) -- QHSLab, Inc. (OTCQB:USAQ) a company focused on providing clinicians with tools to leverage proactive, value-based healthcare solutions through emerging digital

Investment data

Data from SEC filings

Securities sold

Number of investors

Calendar

15 May 22

12 Aug 22

31 Dec 22

Financial summary

Financial statements Chart USAQ financial data

Quarter (USD)	Mar 22	Dec 21	Sep 21	Jun 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 21	Dec 20	Dec 19	Dec 18
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	155.56K	155.56K	155.56K	155.56K	155.56K	155.56K
Cash burn (monthly)	43.77K	(no burn)	20.38K	40.59K	45.81K	38.27K
Cash used (since last report)	193.64K	n/a	90.15K	179.6K	202.68K	169.33K
Cash remaining	-38.08K	n/a	65.41K	-24.04K	-47.12K	-13.78K
Runway (months of cash)	-0.9	n/a	3.2	-0.6	-1.0	-0.4

Beta Read what these cash burn values mean

Financial data from QHSLab earnings reports.

Financial report summary

Competition

DarioHealth • Livongo Health

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: accommodation, adverse, adversely, award, begun, beneficial, Board, callable, client, Codification, collected, commitment, conventional, detailed, education, employee, Independent, inflation, intrinsic, IPA, joint, junior, Miami, million, MSO, multiple, pari, passu, pertinent, promote, refinance, refinanced, replicate, specific, split, standard, target, taxable, Ukraine, underlying, University, war

Removed: advisory, assigned, Beach, cancel, clause, consultant, consummated, event, extinguishment, Florida, modification, MPI, notified, October, offsetting, owner, Palm, par, placement, premium, prepayment, receive, resulting, strategic, terminated, voting, West

From filing 10-Q 2022 Q1

Financial reports

View all